IBO
Income statement / Annual
Last year (2024), Impact BioMedical Inc.'s total revenue was $2.33 M,
and the percentage change from the previous year is not available.
In 2024, Impact BioMedical Inc.'s net income was -$2.05 M.
See Impact BioMedical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
| Period Ended |
12/31/2024 |
| Operating Revenue |
$2.33 M |
| Cost of Revenue |
$0.00
|
| Gross Profit |
$2.33 M
|
| Gross Profit Ratio |
1
|
| Research and Development Expenses |
$91.77 K
|
| General & Administrative Expenses |
$1.02 M
|
| Selling & Marketing Expenses |
$0.00
|
| Selling, General & Administrative Expenses |
$1.02 M
|
| Other Expenses |
$670.05 K
|
| Operating Expenses |
$1.78 M
|
| Cost And Expenses |
$1.78 M
|
| Interest Income |
$5.69 K
|
| Interest Expense |
$168.95 K
|
| Depreciation & Amortization |
$343.46 K
|
| EBITDA |
-$1.54 M |
| EBITDA Ratio |
-0.66
|
| Operating Income Ratio |
0.24
|
| Total Other Income/Expenses Net |
-$2.60 M
|
| Income Before Tax |
-$2.05 M
|
| Income Before Tax Ratio |
-0.88
|
| Income Tax Expense |
$0.00
|
| Net Income |
-$2.05 M
|
| Net Income Ratio |
-0.88
|
| EPS |
-0.01 |
| EPS Diluted |
-0.01 |
| Weighted Average Shares Out |
$232.50 M
|
| Weighted Average Shares Out Diluted |
$232.50 M
|
| Link |
|
